Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19
Jialu Huang, Yubo Ding, Jingwei Yao, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 405-405
Open Access | Times Cited: 17

Showing 17 citing articles:

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 62
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Van‐An Duong, Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 207-207
Open Access | Times Cited: 58
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 48
Advancing vaccine development in genomic era: A paradigm shift in vaccine discovery
Miraj Ud Din, Xiaohui Liu, Hui Jiang, et al.
Progress in Biomedical Engineering (2025) Vol. 7, Iss. 2, pp. 022004-022004
Closed Access | Times Cited: 1
The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine
Ihtisham Ul Haq, Katarzyna Krukiewicz, Galal Yahya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1536-1536
Open Access | Times Cited: 15
Characterization of Spray-Dried Powders Using a Coated Alberta Idealized Nasal Inlet
Kelvin Duong, Maximilian Aisenstat, John Z. Chen, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery (2025) Vol. 38, Iss. 1, pp. 1-12
Closed Access
Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS‐CoV‐2
Xiaohang Chen, Huifei Li, Haoyue Song, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 9
Attitude towards Intranasal Vaccines and Psychological Determinants: Effects on the General Population in Northern Italy
Paola Boragno, Elena Fiabane, Daiana Colledani, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 138-138
Open Access | Times Cited: 5
Polysaccharide-based platforms for nasal delivery: design, features, and perspectives
Enas Elmowafy, Mahmoud E. Soliman
Journal of Pharmaceutical Investigation (2023) Vol. 53, Iss. 5, pp. 571-599
Closed Access | Times Cited: 5
Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis
Xuejuan Zhang, Mengqin Guo, Zhengwei Huang, et al.
Infectious Medicine (2022) Vol. 1, Iss. 2, pp. 103-112
Open Access | Times Cited: 7
Role of Immunoglobulin A in COVID-19 and Influenza Infections
Rohit Tyagi, Srijani Basu, Atika Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1647-1647
Open Access | Times Cited: 3
Immunoregulatory nanomedicine for respiratory infections
Yafang Xiao, Yuanyu Huang, Maobin Xie, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 3, pp. 244-259
Closed Access | Times Cited: 3
Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
Maluta Steven Mufamadi, Mpho Phehello Ngoepe, Ofentse Nobela, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 3
Dipalmitoyl-phosphatidylserine-filled cationic maltodextrin nanoparticles exhibit enhanced efficacy for cell entry and intracellular protein delivery in phagocytic THP-1 cells
Clément Brinkhuizen, Damien Shapman, Alexis Lebon, et al.
BioMolecular Concepts (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The emergence of nanovaccines as a new paradigm in virological vaccinology: a review
Chittaranjan Baruah, Pankaj Das, Papari Devi, et al.
Exploration of Immunology (2023), pp. 361-383
Open Access | Times Cited: 2
Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
Sally A. Helmy, Rami Elmorsi, Soha A.M. Helmy, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103762-103762
Open Access | Times Cited: 4
Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern
Reema Iqbal, Sadia Khan, Haroon Muhammad Ali, et al.
Frontiers in Nanotechnology (2022) Vol. 4
Open Access | Times Cited: 3
Page 1

Scroll to top